高级搜索
放疗联合同步化疗治疗食管癌的临床研究[J]. 肿瘤防治研究, 2005, 32(07): 430-431. DOI: 10.3971/j.issn.1000-8578.2787
引用本文: 放疗联合同步化疗治疗食管癌的临床研究[J]. 肿瘤防治研究, 2005, 32(07): 430-431. DOI: 10.3971/j.issn.1000-8578.2787
A Clinical Study of Combination of the Radiotherapy and Chemotherapy in the Treatment of Patients with Advanced Esophageal Cancer[J]. Cancer Research on Prevention and Treatment, 2005, 32(07): 430-431. DOI: 10.3971/j.issn.1000-8578.2787
Citation: A Clinical Study of Combination of the Radiotherapy and Chemotherapy in the Treatment of Patients with Advanced Esophageal Cancer[J]. Cancer Research on Prevention and Treatment, 2005, 32(07): 430-431. DOI: 10.3971/j.issn.1000-8578.2787

放疗联合同步化疗治疗食管癌的临床研究

A Clinical Study of Combination of the Radiotherapy and Chemotherapy in the Treatment of Patients with Advanced Esophageal Cancer

  • 摘要: 目的 研究放疗联合DF方案治疗食管癌临床疗效。方法 68例食管癌患者随机分为两组,综合组36例,采用放疗联合化疗;对照组32例,单纯行常规外照射治疗。结果 综合组总有效率88.89%,对照组总有效率是62.5%,两组间差异有显著性(P<0.05)。综合组与对照组1、2、3年生存率分别为:63.9%、50%、27.8%和59.3%、34.3%、18.8%。综合组生存率高于对照组。结论 放疗配合化疗能提高中晚期食管癌疗效。

     

    Abstract: Objective  To evaluate the efficacy of the radiotherapy combined chemotherapy in t reating advanced esophageal cancer. Methods  Sixty-eight cases of advanced esophageal cancer were divided into two groups randomly : thirty-six cases in the t reatment group and thirty-two cases in the cont rast group. The cases in the t reatment group t reated with the radiotherapy combined chemotherapy, and the cases in the cont rast group t reated with the radiotherapy simply. Results  The total response rate of the t reatment group and the cont rast group was 88. 89 % and 62. 5 % respectively. The difference between the two groups was significant . The survival rate of 1, 2, 3 years of the t reatment group and the cont rast group were 63. 9 %, 50 %, 27. 8 % and 59. 3 %, 34. 3 %, 18. 8 % respectively. Conclusion  Combination of the radiotherapy and chemotherapy was an effective way in the t reatment of patients with advanced esophageal cancer.

     

/

返回文章
返回